This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost less," CVS Caremark told customers in May.

CVS Health appoints CVS Caremark president “Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for prescription drugs.

The FTC sued UnitedHealth Group's Optum unit, CVS Caremark and Cigna's Express Scripts for allegedly steering diabetes patients towards higher priced insulin.

CVS Caremark recently issued a statement affirming its position and viewpoint on the role of PBMS. 1 As one of the nation’s largest pharmacy benefit managers, it states that its goal is for greater ...

CVS Caremark®, the nation's leading pharmacy benefit manager and a CVS Health® (NYSE: CVS) company, today announced a renewed pledge to American businesses, unions, and health plans — building ...

CVS Caremark laid out its renewed pledge to American businesses, unions and health plans—building on what the company said it is doing to deliver greater transparency, lower drug costs and ...

CVS Caremark, one of the nation’s largest pharmacy benefit managers, will remove Humira from its major national commercial formularies effective April 1 in favor of biosimilar options ...

This year, CVS Health plans to employ the classic "out with the old, in with the new" mantra when it comes to AbbVie’s Humira. | The changes to major commercial formularies will take effect ...

CVS Caremark announced that effective April 1, 2024, Humira will be removed from its major national commercial template formularies and Humira biosimilars will be covered.

As part of updates to its standard formulary, CVS Caremark has removed Amjevita and now prefers Hyrimoz and an unbranded biosimilar.